Skip to main content
Caplight Logo









HistoIndex

HistoIndex

Private
SingaporeHealthcare & Life Scienceshttps://histoindex.com/

Last Round

Series A

Extension

May 2, 2025

Total Funding Raised

$8.51M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

HistoIndex is a medical technology company that provides an AI-powered digital pathology platform using stain-free imaging for the visualization and quantification of fibrosis in biological tissues.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical AI, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

digital pathologymedical AIcomputational pathologyfibrosis quantificationlaboratory developed testLDTclinical trial endpointsimage analysispathology AIbiomarker discoveryMASH researchdeep learning pathologycontract researchmedical imagingpathology software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

HistoIndex Comparables

Compare HistoIndex with similar companies based on industry and business-model similarity.

HistoIndex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmaNest Inc.
82%
Visiopharm
75%
Aignostics
75%

HistoIndex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 2, 2025
GrantDec 14, 2020
Series AMar 11, 2016
VC RoundJun 11, 2015

Key People

Founding team and executive leadership

Gideon Ho

Co-Founder & Chief Commercial Officer, Co-Founder & CEO

Founding Team

HistoIndex Investors

Notable investors and investment history

HistoIndex investors
InvestorRounds
SEEDS CapitalSeries A Extension
OCBC BankSeries A Extension
ZIG VenturesSeries A, VC Round, Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 44% MoM.

  • Jun 22, 2026

    Monthly visitors grew 69% MoM, reaching 2.6K.

HistoIndex Filings

Explore SEC and related filing metadata, where available.

HistoIndex filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about HistoIndex's valuation, stock price, and market status.

Is HistoIndex a public or private company?

HistoIndex is a private company.

What is the current stock price of HistoIndex?

HistoIndex is a private company with no public stock price. No recent secondary market data is available.

How much is HistoIndex worth (valuation)?

Valuation information for HistoIndex is not publicly available.

Can I buy HistoIndex stock?

HistoIndex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was HistoIndex's last funding round?

HistoIndex's most recent funding round was Early Funding on May 2, 2025.

Who are the main investors in HistoIndex?

Key investors in HistoIndex include OCBC Bank.

Will HistoIndex IPO soon?

No public IPO plans have been announced for HistoIndex.

How can I track HistoIndex secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor HistoIndex's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSingapore
Employee Range16
Year Founded2010
Last FundingMay 2, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?